Enzymatic resistance to Betalactam antibiotics within the genus Proteus and evaluation of third and fourth generation cephalosporins resistance phenotypes and genotypes within Proteus mirabilis;Resistencia enzimática a betalactámicos en el genero Proteus y evaluación de los fenotipos y genotipos de resistencia a cefalosporinas de tercera y cuarta generación en Proteus mirabilis

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 23, Issue 3, 2005, Pages 122-126

  Rodríguez, Cynthia ^a   Radice, Marcela ^a,b   Perazzi, Beatriz ^a   Castro, Silvia ^a   Juárez, Josefina ^a   Santini, Pilar ^a   Vay, Carlos ^a   Famiglietti, Angela ^a   Gutkind, Gabriel ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b NONE   (Argentina)

Author keywords

Betalactam; Enximatic resistance; Genus Proteus

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CLAVULANIC ACID; IMIPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM;

AGAR GEL DIFFUSION; ANTIBIOTIC RESISTANCE; ARTICLE; ASSAY; CONTROLLED STUDY; DNA DENATURATION; IODOMETRY; ISOELECTRIC POINT; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTEUS MIRABILIS; PROTEUS PENNERI; PROTEUS VULGARIS;

EID: 16344365638     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1157/13072160     Document Type: Article

References (23)

1. Liu PF, Gur D, Hall LMC, Livermore DM. Survey of the prevalence of β-lactamases amogst 1000 Gram-negative bacilli, isolated consecutively at The Royal London Hospital. J Antimicrob Chemother 1992;30;429-47.
2. Pasteran F, Gagetti P, Galas M, Aguilar J, Melano R, Rapoport M, et al. Extended-Spectrum β-lactamase (ESBL) in Proteus spp. in Argentina. Proceedings of the. 40th. annual Interscience Conference on Antimicrobial Agents and Chemotherapy; 2000 Sep 17-20; Toronto, Ontario, Canada, 2000; p. 124.
3. Quinteros M, Radice M, Gardella N, Rodríguez MM, Costa N, Korbenfeld D, et al. Extended-spectrum β-lactamases in Enterobacteriaceae in Buenos Aires, Argentina, Public Hospitals. Antimicrob Agents Chemother 2003; 47:2864-7.
4. Bauerfeind A, Stemplinger Y, Jungwirth R, Ernst S, Casellas JM. Sequences of β-lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their aminoacid sequences with those of other β-lactamases. Antimicrob Agents Chemother 1996;40:509-13.
5. Rossi A, Gutkind G, Quinteros M, Marino M, Couto E, Tokumoto M, et al. A Proteus mirabilis with Novel Extended Spectrum β-lactamase and 6 different Aminoglycoside CAG) Resistance Genes. Proceedings of the 31st Annual Interscience Conference on Antimicrobial Agents and Chemotherapy; Chicago, 1991.
6. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing; 13th Informational Supplement. National Committee for Clinical Laboratory Standards Document M100-S13; Wayne, 2003.
7. Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988;10;867-78.
8. Matthew M, Harris AM, Marshall MJ, Ross GW. The use of analytical isoelectric focusing for detection and identification of β-lactamases. J Gen Microbiol 1975;88:169-78.
9. Rossi A, Lopardo H, Woloj M, Picandet AM, Marino M, Galas M, et al. Non-typhoid Salmonella spp. resistant to cefotaxime. J Antimicrob Chemother 1995;36:697-702.
10. Power P, Radice M, Barberis C, De Mier C, Mollerach M, Maltagliatti M, et al. Cefotaxime-Hydrolysing β-lactamases in Morganella morganii. European Journal of Clinical Microbiology and Infectious Diseases 1999;18:743-7.
11. Birboim HC, Doly J. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res 1979;7:1513-23.
12. Bush K, Jacoby GA, Medeiros AA. A Functional Classification Scheme for β-lactamases and Its Correlation with Molecular Structure. Antimicrob Agents Chemother 1995;39:1211-33.
13. Bantar C, Famiglietti A, Goldberg M. Three-Year surveillance study of nosocomial bacterial resistance in Argentina. The Antimicrobial Committee, and the National Surveillance Program (SIR) Participants Group. Int J Infect Dis 2000;4:85-90.
14. Pasterán F y Red Whonet-Argentina. Tribu Proteeae: Proteus spp., Providencia spp. y Morganella morganii. Programa Nacional de Control de Calidad en Bacteriología. Servicio de Antimicrobianos. Instituto Nacional de Enfermedades Infecciosas ANLIS "Dr. Carlos G. Malbran" Buenos Aires, Argentina 2001;13:61-84.
15. Chanal C, Sirot D, Romaszko JP, Bret L, Sirot J. Survey of prevalence of extended spectrum β-lactamases among Enterobacteriaceae. J Antimicrob Chemother 1996;38:127-32.
16. Casellas JM, Radice M, Quinteros M, Power P, Rodríguez M, Pagniez G, et al. Valor de distintos métodos para la detección de betalactamasas de espectro extendido en enterobacterias. Reseñas de Infectología y Vacunas 2000; 1:23-7.
17. Bonnet R. Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 2004;4B:1-14.
18. Arpin C, Dubois V, Coulange L, André C, Fischer I, Noury P, et al. Extended- Spectrum β-lactamase-producing Enterobacteriaceae in Community and Private Health Care Centers. Antimicrob Agents Chemother 2003; 47:3506-14.
19. Bonnet R, De Champs C, Sirot D, Chanal C, Labia R, Sirot J. Diversity of TEM Mutants in Proteus mirabilis. Antimicrob Agents Chemother 1999; 43:2671-7.
20. Palzkill T, Thomson KS, Sanders CC, Moland ES, Huang W, Milligan TW. New variant of TEM-10 β-lactamase gene produced by a clinical isolate of Proteus mirabilis. Antimicrob Agents Chemother 1995;39:1199-200.
21. Pitout JD, Thomson DKS, Hanson ND, Ehrhardt AF, Moland ES, Sanders CC. β-lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis isolates recovered in South Africa. Antimicrob Agents Chemother 1998; 42:1350-4.
22. Morlote MM, Navon-Venezia S, Carmeli Y, Venkataraman L. Presence of CTX-M-2 in Proteus mirabilis isolated of an Israeli Hospital. Proceedings of the 43rd annual Interscience Conference on Antimicrobial Agents and Chemoterapy; 2003 sep 14-17; Chicago, Illinois, USA, 2003; p. 110.
23. Casellas JM, Altshuler M, Bantar C, Couto E, De Paulis A, Famiglietti A, et al. Recomendaciones de la Subcomisión de Antimicrobianos de SADE-BAC. Asociación Argentina de Microbiología 1993;99:5. 127-134